BioCentury | Dec 14, 2016
Clinical News

Rekovelle regulatory update

...Rekovelle follitropin delta (FE 999049) Business: Genitourinary Ferring said the European Commission approved an MAA for Rekovelle follitropin delta...
...intracytoplasmic sperm injection (ISCI). Rekovelle is a human cell line-derived recombinant follicle stimulating hormone (rFSH). Julian Zhu FE 999049 follitropin delta Rekovelle Ferring...
BioCentury | Aug 8, 2016
Clinical News

Follitropin delta: Phase III data

...fertilization (IVF) or intracytoplasmic sperm injection (ICSI) showed that an individualized dosing regimen of once-daily follitropin delta...
...of ongoing pregnancy (30.7% vs. 31.6%) and ongoing implantation (35.2% vs. 35.8%). On secondary endpoints, follitropin delta...
...Nov. 16, 2015). Ferring Pharmaceuticals A/S , Saint-Prex, Switzerland Product: Follitropin delta ( Rekovelle ) ( FE 999049...
BioCentury | Nov 16, 2015
Clinical News

Rekovelle follitropin delta regulatory update

...EMA accepted for review an MAA from Ferring for Rekovelle follitropin delta to control ovarian stimulation in...
...assisted reproductive technology therapy, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Rekovelle...
...recombinant follicle stimulating hormone (rFSH). Ferring Pharmaceuticals A/S , Saint-Prex, Switzerland Product: Rekovelle follitropin delta ( FE 999049...
BioCentury | Jun 30, 2014
Company News

Roche, Ferring deal

...deal, the companies will use Roche’s Elecsys AMH assay in Ferring’s Phase III program of FE 999049...
...to qualify, validate, document and seek regulatory approval of the assay as a companion diagnostic. FE 999049...
Items per page:
1 - 4 of 4